1. Home
  2. CPRX vs TCBI Comparison

CPRX vs TCBI Comparison

Compare CPRX & TCBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPRX
  • TCBI
  • Stock Information
  • Founded
  • CPRX 2002
  • TCBI 1996
  • Country
  • CPRX United States
  • TCBI United States
  • Employees
  • CPRX N/A
  • TCBI N/A
  • Industry
  • CPRX Biotechnology: Pharmaceutical Preparations
  • TCBI Major Banks
  • Sector
  • CPRX Health Care
  • TCBI Finance
  • Exchange
  • CPRX Nasdaq
  • TCBI Nasdaq
  • Market Cap
  • CPRX 2.9B
  • TCBI 2.9B
  • IPO Year
  • CPRX 2006
  • TCBI N/A
  • Fundamental
  • Price
  • CPRX $21.81
  • TCBI $86.98
  • Analyst Decision
  • CPRX Strong Buy
  • TCBI Hold
  • Analyst Count
  • CPRX 6
  • TCBI 14
  • Target Price
  • CPRX $32.83
  • TCBI $79.21
  • AVG Volume (30 Days)
  • CPRX 1.4M
  • TCBI 386.5K
  • Earning Date
  • CPRX 08-06-2025
  • TCBI 07-17-2025
  • Dividend Yield
  • CPRX N/A
  • TCBI N/A
  • EPS Growth
  • CPRX 178.13
  • TCBI N/A
  • EPS
  • CPRX 1.57
  • TCBI 1.74
  • Revenue
  • CPRX $534,645,999.00
  • TCBI $891,496,000.00
  • Revenue This Year
  • CPRX $16.37
  • TCBI $44.91
  • Revenue Next Year
  • CPRX $8.80
  • TCBI $9.57
  • P/E Ratio
  • CPRX $13.93
  • TCBI $50.20
  • Revenue Growth
  • CPRX 29.97
  • TCBI N/A
  • 52 Week Low
  • CPRX $15.34
  • TCBI $56.24
  • 52 Week High
  • CPRX $26.58
  • TCBI $91.80
  • Technical
  • Relative Strength Index (RSI)
  • CPRX 42.36
  • TCBI 78.32
  • Support Level
  • CPRX $20.62
  • TCBI $81.56
  • Resistance Level
  • CPRX $22.06
  • TCBI $88.11
  • Average True Range (ATR)
  • CPRX 0.66
  • TCBI 2.88
  • MACD
  • CPRX 0.03
  • TCBI 0.68
  • Stochastic Oscillator
  • CPRX 56.67
  • TCBI 93.37

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).

About TCBI Texas Capital Bancshares Inc.

Texas Capital Bancshares Inc is a secured lender, with the majority of the loans held for investment, excluding mortgage finance loans and other national lines of business. The company's national lines of business provide specialized lending products to businesses throughout the United States. The bank operates in Texas' main metropolitan areas, like Austin, Dallas, Fort Worth, Houston, and San Antonio.

Share on Social Networks: